According to Ionis Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.26 B. a decrease over its 2022 earnings that were of -$0.26 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.26 B | 1.25% |
2022 | -$0.26 B | 793.58% |
2021 | -$28.56 M | -77.29% |
2020 | -$0.13 B | -131.79% |
2019 | $0.39 B | -1361.08% |
2018 | -$31.37 M | -196.52% |
2017 | $32.49 M | -172.49% |
2016 | -$44.83 M | -12.4% |
2015 | -$51.18 M | 59.02% |
2014 | -$32.19 M | -31.83% |
2013 | -$47.21 M | -11.66% |
2012 | -$53.44 M | -21.48% |
2011 | -$68.06 M | 42% |
2010 | -$47.93 M | 151.02% |
2009 | -$19.1 M | |
2007 | -$38.95 M | -43.27% |
2006 | -$68.66 M | 36.7% |
2005 | -$50.23 M | -41.21% |
2004 | -$85.43 M | 10.69% |
2003 | -$77.18 M | 56.1% |
2002 | -$49.44 M | 7.24% |
2001 | -$46.11 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.17 M | -99.16% | Bahamas |
NRC Health
NRC | $40.82 M | -115.80% | ๐บ๐ธ USA |